The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.

 
Web www.patentalert.com

> N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase

~ 00374